Skip to main content
background gradient

Volume 8Issue 13

Editorial

White Paper

Free Access
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit
  • Steven D Pearson,
  • Celia Segel,
  • Amanda Cole,
  • Chris Henshall, and
  • Adrian Towse
pp1045–1054
Published Online:27 September 2019
Preview Abstract

Systematic Review

Free Access
Positive deviance approaches to improving vaccination coverage rates within healthcare systems: a systematic review
  • Sonal Singh,
  • Kathleen M Mazor, and
  • Kimberly A Fisher
pp1055–1065
Published Online:3 October 2019
Preview Abstract

Research Article

Open Access
Second-line rituximab–bendamustine versus rituximab–gemcitabine–oxaliplatin in diffuse large B-cell lymphoma in the real world
  • Raluca Ionescu-Ittu,
  • Aijing Shang,
  • Nancy V Velde,
  • Annie Guerin,
  • Yilu Lin,
  • Lizheng Shi,
  • Sherry Shi, and
  • Naseer Qayum
pp1067–1075
Published Online:27 August 2019
Preview Abstract
Open Access
Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia
  • Saurabh Aggarwal,
  • Michael Serbin, and
  • Chuck Yonan
pp1077–1088
Published Online:29 August 2019
Preview Abstract
Free Access
Twelve-month healthcare utilization and expenditures in Medicare fee-for-service patients with clinically significant mitral regurgitation
  • Hirsch S Mehta,
  • Joanna Van Houten,
  • Patrick Verta,
  • Candace Gunnarsson,
  • Sarah Mollenkopf, and
  • David P Cork
pp1089–1097
Published Online:7 October 2019
Preview Abstract
Open Access
Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost–effectiveness and budget impact
  • Carla Rognoni and
  • Simone Gerzeli
pp1099–1110
Published Online:3 October 2019
Preview Abstract
Free Access
Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia
  • Brooke M Faught,
  • Graziella Soulban,
  • Jason Yeaw,
  • Christiane Maroun,
  • Katharine Coyle,
  • Samuel Schaffer, and
  • Mitch DeKoven
pp1111–1123
Published Online:21 August 2019
Preview Abstract
Open Access
Cost–effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China
  • Soyoung Kim,
  • Adrian Yit Reen Ooi,
  • Thomas Stephens, and
  • Hongsi Jiang
pp1125–1141
Published Online:3 October 2019
Preview Abstract